Ocuphire Pharma (NASDAQ: OCUP)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by HC Wainwright & Co. on Wednesday, November 24, 2021. The analyst firm set a price target for 26.00 expecting OCUP to rise to within 12 months (a possible 1180.79% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $2.03 last updated Today at May 24, 2022, 7:17 PM UTC.
There are no upcoming dividends for Ocuphire Pharma.
Ocuphire Pharma’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Ocuphire Pharma.
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.